Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 9570129, 9 pages
https://doi.org/10.1155/2017/9570129
Review Article

TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms

Institute of Clinical Chemistry, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany

Correspondence should be addressed to René Huber; ed.revonnah-hm@ener.rebuh and Korbinian Brand; ed.revonnah-hm@nainibrok.dnarb

Received 27 July 2017; Accepted 25 September 2017; Published 8 November 2017

Academic Editor: Kebin Hu

Copyright © 2017 René Huber et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Brenner, H. Blaser, and T. W. Mak, “Regulation of tumour necrosis factor signalling: live or let die,” Nature Reviews Immunology, vol. 15, no. 6, pp. 362–374, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. D. L. Fraker, M. C. Stovroff, M. J. Merino, and J. A. Norton, “Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity,” The Journal of Experimental Medicine, vol. 168, no. 1, pp. 95–105, 1988. View at Publisher · View at Google Scholar
  3. B. Zingarelli, M. Makhalouf, P. Halushka, A. Caputi, and J. A. Cook, “Altered macrophage function in tumor necrosis factor α- and endotoxin-induced tolerance,” Journal of Endotoxin Research, vol. 2, pp. 247–254, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Gunther, N. Vogt, K. Hampel et al., “Identification of two forms of TNF tolerance in human monocytes: differential inhibition of NF-κB/AP-1- and PP1-associated signaling,” The Journal of Immunology, vol. 192, no. 7, pp. 3143–3155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ferlito, O. G. Romanenko, S. Ashton, F. Squadrito, P. V. Halushka, and J. A. Cook, “Effect of cross-tolerance between endotoxin and TNF-α or IL-1β on cellular signaling and mediator production,” Journal of Leukocyte Biology, vol. 70, no. 5, pp. 821–829, 2001. View at Google Scholar
  6. S. H. Park, K. H. Park-Min, J. Chen, X. Hu, and L. B. Ivashkiv, “Tumor necrosis factor induces GSK3 kinase–mediated cross-tolerance to endotoxin in macrophages,” Nature Immunology, vol. 12, no. 7, pp. 607–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Waller, L. Kesper, J. Hirschfeld et al., “Porphyromonas gingivalis outer membrane vesicles induce selective tumor necrosis factor tolerance in a toll-like receptor 4- and mTOR-dependent manner,” Infection and Immunity, vol. 84, no. 4, pp. 1194–1204, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. D. L. Fraker, B. C. Sheppard, and J. A. Norton, “Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice,” Cancer Research, vol. 50, no. 8, pp. 2261–2267, 1990. View at Google Scholar
  9. A. Zwergal, M. Quirling, B. Saugel et al., “C/EBPβ blocks p65 phosphorylation and thereby NF-κB-mediated transcription in TNF-tolerant cells,” The Journal of Immunology, vol. 177, no. 1, pp. 665–672, 2006. View at Publisher · View at Google Scholar
  10. F. Haimerl, A. Erhardt, G. Sass, and G. Tiegs, “Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-α-induced hepatocyte survival,” The Journal of Biological Chemistry, vol. 284, no. 1, pp. 495–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. B. Haudek, D. D. Bryant, and B. P. Giroir, “Differential regulation of myocardial NF κ B following acute or chronic TNF- α exposure,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 6, pp. 1263–1271, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. B. C. Sheppard and J. A. Norton, “Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor,” Surgery, vol. 109, no. 6, pp. 698–705, 1991. View at Google Scholar
  13. J. J. Klir, J. L. McClellan, W. Kozak, Z. Szelenyi, G. H. Wong, and M. J. Kluger, “Systemic but not central administration of tumor necrosis factor-alpha attenuates LPS-induced fever in rats,” American Journal of Physiology, vol. 268, no. 2, pp. R480–R486, 1995. View at Google Scholar
  14. J. M. Goldbach, J. Roth, B. Storr, and E. Zeisberger, “Repeated infusions of TNF-alpha cause attenuation of the thermal response and influence LPS fever in guinea pigs,” American Journal of Physiology, vol. 270, no. 4, pp. R749–R754, 1996. View at Google Scholar
  15. J. S. Patton, P. M. Peters, J. McCabe et al., “Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents,” The Journal of Clinical Investigation, vol. 80, no. 6, pp. 1587–1596, 1987. View at Publisher · View at Google Scholar
  16. G. Sass, K. Koerber, and G. Tiegs, “TNF tolerance and cytotoxicity in the liver: the role of interleukin-1β, inducible nitric oxide-synthase and heme oxygenase-1 in D-galactosamine-sensitized mice,” Inflammation Research, vol. 51, no. 5, pp. 229–235, 2002. View at Publisher · View at Google Scholar
  17. S. H. Socher, A. Friedman, and D. Martinez, “Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice,” The Journal of Experimental Medicine, vol. 167, no. 6, pp. 1957–1962, 1988. View at Publisher · View at Google Scholar
  18. H. R. Alexander, B. C. Sheppard, J. C. Jensen et al., “Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis,” The Journal of Clinical Investigation, vol. 88, no. 1, pp. 34–39, 1991. View at Publisher · View at Google Scholar
  19. N. Takahashi, P. Brouckaert, and W. Fiers, “Mechanism of tolerance to tumor necrosis factor: receptor-specific pathway and selectivity,” American Journal of Physiology, vol. 269, no. 2, pp. R398–R405, 1995. View at Google Scholar
  20. R. S. Hotchkiss and D. W. Nicholson, “Apoptosis and caspases regulate death and inflammation in sepsis,” Nature Reviews Immunology, vol. 6, no. 11, pp. 813–822, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Sass, N. D. Shembade, and G. Tiegs, “Tumour necrosis factor α (TNF)–TNF receptor 1-inducible cytoprotective proteins in the mouse liver: relevance of suppressors of cytokine signalling,” Biochemical Journal, vol. 385, no. 2, pp. 537–544, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. H. Porter, M. Arnold, and W. Langhans, “TNF-α tolerance blocks LPS-induced hypophagia but LPS tolerance fails to prevent TNF-α-induced hypophagia,” American Journal of Physiology, vol. 274, no. 3, pp. R741–R745, 1998. View at Google Scholar
  23. D. B. Hill, J. Schmidt, S. I. Shedlofsky, D. A. Cohen, and C. J. McClain, “In vitro tumor necrosis factor cytotoxicity in Hep G2 liver cells,” Hepatology, vol. 21, no. 4, pp. 1114–1119, 1995. View at Publisher · View at Google Scholar
  24. T. O. Yarovinsky, L. S. Powers, N. S. Butler, M. A. Bradford, M. M. Monick, and G. W. Hunninghake, “Adenoviral infection decreases mortality from lipopolysaccharide-induced liver failure via induction of TNF-α tolerance,” The Journal of Immunology, vol. 171, no. 5, pp. 2453–2460, 2003. View at Publisher · View at Google Scholar
  25. I. A. Clark, G. Chaudhri, and W. B. Cowden, “Roles of tumour necrosis factor in the illness and pathology of malaria,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 83, no. 4, pp. 436–440, 1989. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Weber, C. Sydlik, M. Quirling et al., “Transcriptional inhibition of interleukin-8 expression in tumor necrosis factor-tolerant cells: evidence for involvement of C/EBPβ,” The Journal of Biological Chemistry, vol. 278, no. 26, pp. 23586–23593, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Laegreid, L. Thommesen, T. G. Jahr, A. Sundan, and T. Espevik, “Tumor necrosis factor induces lipopolysaccharide tolerance in a human adenocarcinoma cell line mainly through the TNF p55 receptor,” The Journal of Biological Chemistry, vol. 270, no. 43, pp. 25418–25425, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Ginis, R. Jaiswal, D. Klimanis, J. Liu, J. Greenspon, and J. M. Hallenbeck, “TNF-α–induced tolerance to ischemic injury involves differential control of NF-κB transactivation: the role of NF-κB association with p300 adaptor,” Journal of Cerebral Blood Flow & Metabolism, vol. 22, no. 2, pp. 142–152, 2002. View at Publisher · View at Google Scholar
  29. S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada, “Establishment and characterization of a human acute monocytic leukemia cell line (THP-1),” International Journal of Cancer, vol. 26, no. 2, pp. 171–176, 1980. View at Publisher · View at Google Scholar
  30. R. Huber, D. Pietsch, J. Gunther, B. Welz, N. Vogt, and K. Brand, “Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks,” Cellular and Molecular Life Sciences, vol. 71, no. 1, pp. 63–92, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Huber, D. Pietsch, T. Panterodt, and K. Brand, “Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage,” Cellular Signalling, vol. 24, no. 6, pp. 1287–1296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Buss, A. Dörrie, M. L. Schmitz et al., “Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity,” The Journal of Biological Chemistry, vol. 279, no. 48, pp. 49571–49574, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Shen, N. Li, P. Gade et al., “IL-17 receptor signaling inhibits C/EBPβ by sequential phosphorylation of the regulatory 2 domain,” Science Signaling, vol. 2, no. 59, article ra8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Sabio and R. J. Davis, “TNF and MAP kinase signalling pathways,” Seminars in Immunology, vol. 26, no. 3, pp. 237–245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. K. A. Zielinska, L. Van Moortel, G. Opdenakker, K. De Bosscher, and P. E. Van den Steen, “Endothelial response to glucocorticoids in inflammatory diseases,” Frontiers in Immunology, vol. 7, p. 592, 2016. View at Publisher · View at Google Scholar
  36. R. Bikker, M. Christmann, K. Preuß et al., “TNF phase III signalling in tolerant cells is tightly controlled by A20 and CYLD,” Cellular Signalling, vol. 37, pp. 123–135, 2017. View at Publisher · View at Google Scholar
  37. I. E. Wertz, K. M. O’Rourke, H. Zhou et al., “De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling,” Nature, vol. 430, no. 7000, pp. 694–699, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. I. E. Wertz, K. Newton, D. Seshasayee et al., “Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation,” Nature, vol. 528, no. 7582, pp. 370–375, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Lork, K. Verhelst, and R. Beyaert, “CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different,” Cell Death and Differentiation, vol. 24, no. 7, pp. 1172–1183, 2017. View at Publisher · View at Google Scholar
  40. N. Shembade, R. Pujari, N. S. Harhaj, D. W. Abbott, and E. W. Harhaj, “The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1,” Nature Immunology, vol. 12, no. 9, pp. 834–843, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Shembade, K. Parvatiyar, N. S. Harhaj, and E. W. Harhaj, “The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-κB signalling,” The EMBO Journal, vol. 28, no. 5, pp. 513–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Shembade, N. S. Harhaj, K. Parvatiyar et al., “The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20,” Nature Immunology, vol. 9, no. 3, pp. 254–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Ma and B. A. Malynn, “A20: linking a complex regulator of ubiquitylation to immunity and human disease,” Nature Reviews Immunology, vol. 12, no. 11, pp. 774–785, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Verstrepen, I. Carpentier, K. Verhelst, and R. Beyaert, “ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling,” Biochemical Pharmacology, vol. 78, no. 2, pp. 105–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Verbinnen, M. Ferreira, and M. Bollen, “Biogenesis and activity regulation of protein phosphatase 1,” Biochemical Society Transactions, vol. 45, no. 1, pp. 89–99, 2017. View at Publisher · View at Google Scholar
  46. Y. Tsuchiya, O. Nakabayashi, and H. Nakano, “FLIP the switch: regulation of apoptosis and necroptosis by cFLIP,” International Journal of Molecular Sciences, vol. 16, no. 12, pp. 30321–30341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Aki, W. Zhang, and Y. C. Liu, “The E3 ligase Itch in immune regulation and beyond,” Immunological Reviews, vol. 266, no. 1, pp. 6–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Goto, T. Yoshioka, R. I. Young, T. Battelino, C. L. Anderson, and W. P. Zeller, “A sublethal dose of LPS to pregnant rats induces TNF-alpha tolerance in their 0-day-old offspring,” American Journal of Physiology, vol. 273, no. 3, pp. R1158–R1162, 1997. View at Google Scholar
  49. U. Deiters, M. Gumenscheimer, C. Galanos, and P. F. Muhlradt, “Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses,” Infection and Immunity, vol. 71, no. 8, pp. 4456–4462, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. J. J. Seeley and S. Ghosh, “Tolerization of inflammatory gene expression,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 78, pp. 69–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. H. W. Ziegler-Heitbrock, “Molecular mechanism in tolerance to lipopolysaccharide,” Journal of Inflammation, vol. 45, no. 1, pp. 13–26, 1995. View at Google Scholar
  52. H. R. Alexander, G. G. Wong, G. M. Doherty, D. J. Venzon, D. L. Fraker, and J. A. Norton, “Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor,” The Journal of Experimental Medicine, vol. 175, no. 4, pp. 1139–1142, 1992. View at Publisher · View at Google Scholar
  53. C. D. Buckley, D. W. Gilroy, C. N. Serhan, B. Stockinger, and P. P. Tak, “The resolution of inflammation,” Nature Reviews Immunology, vol. 13, no. 1, pp. 59–66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Nathan and A. Ding, “Nonresolving inflammation,” Cell, vol. 140, no. 6, pp. 871–882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. C. N. Serhan and J. Savill, “Resolution of inflammation: the beginning programs the end,” Nature Immunology, vol. 6, no. 12, pp. 1191–1197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. L. M. Workman and H. Habelhah, “TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification,” Cellular Signalling, vol. 25, no. 8, pp. 1654–1664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. S. L. Werner, J. D. Kearns, V. Zadorozhnaya et al., “Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20,” Genes & Development, vol. 22, no. 15, pp. 2093–2101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. G. S. Firestein and I. B. McInnes, “Immunopathogenesis of rheumatoid arthritis,” Immunity, vol. 46, no. 2, pp. 183–196, 2017. View at Publisher · View at Google Scholar
  59. G. Rogler, K. Brand, D. Vogl et al., “Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa,” Gastroenterology, vol. 115, no. 2, pp. 357–369, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. J. J. O’Shea, A. Ma, and P. Lipsky, “Cytokines and autoimmunity,” Nature Reviews Immunology, vol. 2, no. 1, pp. 37–45, 2002. View at Publisher · View at Google Scholar
  61. R. S. Hotchkiss and I. E. Karl, “The pathophysiology and treatment of sepsis,” The New England Journal of Medicine, vol. 348, no. 2, pp. 138–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. R. S. Hotchkiss, G. Monneret, and D. Payen, “Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy,” Nature Reviews Immunology, vol. 13, no. 12, pp. 862–874, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. R. S. Hotchkiss, L. L. Moldawer, S. M. Opal, K. Reinhart, I. R. Turnbull, and J. L. Vincent, “Sepsis and septic shock,” Nature Reviews Disease Primers, vol. 2, article 16045, 2016. View at Publisher · View at Google Scholar
  64. F. Balkwill, “Tumour necrosis factor and cancer,” Nature Reviews Cancer, vol. 9, no. 5, pp. 361–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. N. Fullerton and D. W. Gilroy, “Resolution of inflammation: a new therapeutic frontier,” Nature Reviews Drug Discovery, vol. 15, no. 8, pp. 551–567, 2016. View at Publisher · View at Google Scholar · View at Scopus